Disclosed is an opioid antagonist composition and an oral dosage form comprising an opioid antagonist particle in a coating which is insoluble in the gastrointestinal system or an opioid antagonist dispersed in a matrix that renders the antagonist substantially non-releasable or an opioid antagonist dispersed in a melt-extruded matrix.